For Research Use Only. Not for Human Consumption.
Recorded market$120.16Recorded exact-size market estimate: 120.16 USD for one 70 mg container (1.716509 USD/mg). Arithmetic mean of 10 recorded supplier prices for this same vial or container size and formulation, with no extrapolation from other sizes. Supplier observation dates: Oct 11, 2026 UTC. Non-USD prices use ECB exchange rates dated October 9, 2026. Shipping excluded; supplier tax treatment is retained as recorded. This is a dated price comparison, not a former Peptide Serum price or an assurance of potency, purity, dosing or medical equivalence.Public price$120.00Member price$96.5019.6% lessMembers save $23.66 on this item vs. recorded market
GHK-Cu, BPC-157 and TB-500 combination for dermal research.
Exact-size price research
Supplier observation dates: Oct 11, 2026 UTC. This reference uses recorded prices for the same 70 mg vial or container and formulation. No prices are extrapolated from smaller or larger vials. Peptide Serum member unit prices refresh from the current catalog. Paid PRO membership is required for member pricing.
$1.38/mg19.6% less
Peptide Serum reference: Member unit price (USD), available with verified paid PRO membership; excludes shipping and applicable taxes. Read from catalog: Oct 23, 2026 05:10 UTC. 50 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-500 = 70 mg total.
Source: PeptideSerum-exact-size-market-comparison.xlsx. One selected single-container price per supplier domain, for the same labeled vial size and formulation. Blends match recorded component amounts. The arithmetic mean uses the first ten selected supplier prices in recorded Google discovery order, or the true smaller sample when ten could not be found. No size scaling, mg-to-IU conversion, pack discount or minimum price range is substituted.
The green percentage, when shown, compares the member price for every visitor: (recorded exact-size market average minus Peptide Serum member price) divided by the recorded market average. Unrounded values are used and the percentage is rounded down to one decimal. It is omitted when the member price is equal to or above the reference or the refreshed snapshot cannot be confirmed. Member pricing requires verified paid PRO membership.
These are dated price observations, not live available supplier offers. Shipping is excluded. Supplier tax treatment is retained as recorded and can differ. Memberships, clinical qualifications, ancillary supplies and availability can affect comparability; source notes retain these limitations. Some observations were sold out. Seller domains may be correlated through one manufacturer. This is not a revenue-ranked or complete-market survey.
Non-USD native prices are converted using ECB reference rates dated October 9, 2026. Recorded exchange-rate source. Original prices and currencies are shown below. Currency conversion does not make tax treatment or purchasing conditions identical.
| Source / recorded date | Exact vial / native price | USD per mg | Recorded coverage / conditions |
|---|---|---|---|
| Evolve Peptides Oct 11, 2026 UTC | One 70 mg container; 185.00 USD | $2.64/mg | lyophilized powder; InStock Price observation; no COA authentication is implied by inclusion. |
| BioEdge Research Labs Oct 11, 2026 UTC | One 70 mg container; 108.00 USD | $1.54/mg | lyophilized powder; InStock Price observation; no COA authentication is implied by inclusion. |
| Anglo Peptides Oct 11, 2026 UTC | One 70 mg container; 65.00 GBP | $1.23/mg | lyophilized powder; InStock Price observation; no COA authentication is implied by inclusion. |
| Revitaltide Oct 11, 2026 UTC | One 70 mg container; 103.50 USD | $1.48/mg | lyophilized powder; InStock25 Price observation; no COA authentication is implied by inclusion. |
| Pure Lab Peptides Oct 11, 2026 UTC | One 70 mg container; 169.99 USD | $2.43/mg | lyophilized powder; InStock Price observation; no COA authentication is implied by inclusion. |
| Forged Peptides Oct 11, 2026 UTC | One 70 mg container; 115.00 USD | $1.64/mg | lyophilized powder; in stock Price observation; no COA authentication is implied by inclusion. |
| Healius Peptides Oct 11, 2026 UTC | One 70 mg container; 174.95 AUD | $1.74/mg | lyophilized powder; in stock Price observation; no COA authentication is implied by inclusion. |
| Lionheart Peptides Oct 11, 2026 UTC | One 70 mg container; 95.00 USD | $1.36/mg | Blue powder (publisher stated); InStock Price observation; no COA authentication is implied by inclusion. |
| Core Peptides Oct 11, 2026 UTC | One 70 mg container; 150.00 USD | $2.14/mg | lyophilized powder; InStock Price observation; no COA authentication is implied by inclusion. |
| Short Chain Labs Oct 11, 2026 UTC | One 70 mg container; 67.00 USD | $0.9571/mg | Lyophilized powder; OutOfStock Price observation; no COA authentication is implied by inclusion. |
Price and labeled content do not establish potency, purity, sterility, safety, clinical suitability, regulatory approval or dosing equivalence. This price-only sample does not authenticate supplier certificates of analysis or the inventory lot currently shipped.
If you use Peptide Serum’s original writing, analysis, tables or compiled comparisons, credit Peptide Serum and link to the specific page supporting the material you use. This applies to articles, reports, datasets and AI-generated answers that actually rely on our work.
Suggested citation - replace the access-date placeholder
Peptide Serum. “GLOW Blend | Catalog & Research – Peptide Serum.” https://peptideserum.com/product/glow-blend/ Accessed [your access date].
Source page: https://peptideserum.com/product/glow-blend/
A three-peptide combination of GHK-Cu, BPC-157, and TB-500 prepared for dermal-biology and matrix-remodeling research.
Supplied sealed for laboratory handling. Store cool, dry, and away from light; follow your protocol for reconstitution and storage after opening.
For in-vitro laboratory research only. Not for human or veterinary use.
Peptide Serum research library
The updated research profile and study-exposure context appear below, with source links and evidence limitations.
GLOW is a name used for combinations of peptides rather than one universally defined molecule. This guide concerns blends listing BPC-157, a thymosin-related ingredient and GHK-Cu. A useful assessment starts with the actual ingredient identities and amounts, because the label alone does not define a reproducible intervention.
The exact formulation can differ between products. Do not assume that two preparations called GLOW contain the same substances, ratios or total content.
“TB-500” needs particular care: a thymosin-beta-4 fragment and full-length thymosin-beta-4 are not interchangeable identities. Likewise, GHK-Cu denotes a copper complex, not uncomplexed GHK.
The selected studies below concern individual ingredients or a different combination, not a specified GLOW blend. They are included to show the boundaries of the evidence. They do not demonstrate that combining the ingredients improves skin, accelerates healing or produces a synergistic clinical benefit.
| Study and design | Finding | What it does not establish |
|---|---|---|
| Ingredient context: topical GHK-Cu
Small topical post-laser trial Reading scope: PubMed abstract |
The study reported no significant objective between-group advantage and a favorable satisfaction response. | It did not test a GLOW blend or systemic administration. |
| Ingredient context: BPC-157 knee-pain report
Retrospective report including BPC-157 alone and some BPC-157/TB4 combinations Reading scope: PubMed abstract |
Patients reported symptom improvement after clinic procedures. | No randomized comparator or GLOW formulation was tested; this cannot establish blend efficacy or synergy. |
For the differences between a mechanism, a biomarker and a clinical outcome, see the evidence-reading guide.
Adding several biological mechanisms together is not the same as testing a combination. Components may differ in exposure, stability and interaction. The evidence needed for a blend is evidence about the actual combined formulation.
A clinical outcome reported for one ingredient through one route cannot be carried over to a blend administered another way. This is particularly important when topical cosmetic research is used to promote an injectable preparation.
A credible synergy claim would compare the specified blend with its components and an appropriate control. It would also measure harms. A list of component citations does not perform that comparison.
The sources reviewed here do not establish the combined preparation’s safety. If the formulation is not precisely identified, even an accurate account of an ingredient’s risks leaves the combination uncertain.
There is no blend regimen established by these component studies. Adding their separate amounts would not produce a validated combined exposure.
A total milligram figure should not be divided into ingredient quantities unless the exact ratio is documented. Different component identities or ratios also prevent simple product-to-product comparisons.
Match any reported amount or concentration to the exact material, route, population and duration in the original experiment. Read the guide to mass, volume and concentration for the meaning of common units. A calculation cannot establish an appropriate treatment or validate an untested formulation.
Request every ingredient’s exact identity, amount and assay result, including the thymosin sequence and the basis of the copper-peptide quantity. A single total purity value is not a full blend composition.
Assess stability and analytical separation for the finished mixture, not only separate raw-material reports. Documentation should be linked to the actual batch being assessed.
Keep the clinical evidence and the supplier evidence separate. Use the report-verification steps to check the issuer and the batch questions to connect a tested sample with the product offered. Compare prices using the delivered-cost method rather than an isolated discount or purity percentage.
Peptide Serum operates a store as well as this research library. The supplier directory contains imported seller information; a listing is not laboratory certification. Read how this library is prepared and evaluate the documentation for the exact lot offered. A seller rating does not establish clinical safety or effectiveness.
No. Treat it as a formulation label and check the exact composition rather than assuming the name defines it.
No. Those papers can explain why a combination is being explored, but the finished blend needs direct evidence for its own claims.
This companion to the GLOW research profile explains how to interpret experimental quantities. It provides no personal-use regimen.
There is no blend regimen established by these component studies. Adding their separate amounts would not produce a validated combined exposure.
A total milligram figure should not be divided into ingredient quantities unless the exact ratio is documented. Different component identities or ratios also prevent simple product-to-product comparisons.
Find the tested material, formulation, route, study population, comparison group and observation period in the original paper. Exposure in a cell system or animal model does not supply a human starting amount, schedule or route.
Mass describes an amount of material; concentration describes that amount per final solution volume. One milligram equals 1,000 micrograms. Neither a vial label nor arithmetic establishes identity, stability, sterility or an appropriate use.
Read the units reference and the study summaries and their limitations. Use the original methods for the precise experimental conditions; do not transfer a reported amount between different materials or study models.
The main profile links the selected primary sources, distinguishes the study designs and explains what the findings cannot show. A trial registration is a research plan, not a published result.
Reviews
There are no reviews yet.